MPIP: Melanoma Patients Information Page

The MPIP is the oldest and largest community of people affected by melanoma hosted through the Melanoma Research Foundation. It is designed to provide support and information to caregivers, patients, family and friends. Once you have been touched by melanoma—either as a patient or as a family member or friend of a patient—you become part of a community. It is not a community anyone joins willingly. But if you must be part of this group, you will find no better place to find the tools you need in your journey with this cancer, and the friends who can make that journey more bearable.

The information on the bulletin board is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

Expand/ Collapse Topic
Replies By
View Topic
kiser7677's picture
Replies 2
Last reply 5/21/2013 - 10:53pm
Replies by: washoegal, Fen

My husband was diagnosed with stage 3 melanoma last June 2012. He found a lump under his left arm. He had the lymph node removed and it was melanoma. After that they went back in and removed 8 more lymph nodes and they were all negative. He also had a mole removed, the mole was also Melanoma, but they had trouble getting a positive for Melanoma. The biopsy at the office was negative, the positive didn't come until it was completely removed with the positive lymph node at surgery. All scans were clear at that time. In September he started the intro a. And the in January of 2013 he had a reoccurrence in the exact same spot. Since he was taking the treatments we thought it was scar tissue. The Melanoma was directly behind his scar. So, that was removed. It was decided after that to do radiation. So, in March he started his radiation and the day after he finished, he found another lump in the same exact spot and that too is Melanoma. That's currently where we stand. He had a scan last Friday and we have our follow up appointment this Thursday and I pray it hasn't spread anywhere else. I guess my first question what's some other treatments and is this happen a lot? To get Melanoma with taking these treatments? Thanks for the info.

Login or register to post replies.

My dad is in cycle 2. I would like feedback :)

Login or register to post replies.

bikerwifee's picture
Replies 7
Last reply 5/21/2013 - 9:50pm

Been a while since I posted. I do check on the board each day. Lynn finished the aberaxene wasnt much help. Talked about a clinical trial in Charlotte if brain was stable but the did a mri of brain. The 32 spots they treated are desd are dying only empty cavitys but of course there was 7 new ones and they offered gamma knife ahain they say it works so good for Lynn just dont know if hes up to the sixth one or not. They are talking about temador not to sure about that either. I dont think we have many options left. Lynn been really sick this week guess he picked up a virus at hospital Monday and on top of it the place they cut off on back got
infected. Its devasting the Drs havent give us much hope and Lynn wants to fight so bad

I have missed talking to my family on her and I have been wonder about gabsound.

Login or register to post replies.

Anonymous's picture
Replies 4
Last reply 5/21/2013 - 11:37am
Replies by: Anonymous


Journal of Investigative Dermatology (2013) 133, 1460–1462; doi:10.1038/jid.2013.34

Circulating Melanoma Cells as a Predictive Biomarker

Giorgos Karakousis1, Ruifeng Yang2 and Xiaowei Xu2

  1. 1Department of Surgery, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
  2. 2Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA

Correspondence: Xiaowei Xu, Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA. E-mail:


The prognosis of patients with metastatic melanoma has improved significantly with targeted therapeutic agents and immunotherapies. Detection of early melanoma recurrence after treatment will be beneficial to switch patients who fail on one therapy to different modalities. Circulating tumor cells (CTCs) are cancer cells released by a tumor into the peripheral blood. These cells hold potential as prognostic, predictive, and pharmacodynamic biomarkers for treatment. In this issue, Khoja et al. report that melanoma CTCs can be detected using Melcam and high molecular weight melanoma–associated antibody. They found that in 101 stage IV melanoma patients, CTC numbers ranged between 0 and 36/7.5ml blood; 26% of the patients had greater than or equal to2 CTCs at baseline. The CTC number (greater than or equal to2 CTCs) at baseline was significantly prognostic for median overall survival (OS) in univariate and multivariate analysis. Patients receiving treatment where CTC numbers remained greater than or equal to2 CTCs during their treatment had shorter median OS than those who maintained <2 CTCs (7 vs. 10 months, hazard ratio 0.34, 95% confidence interval 0.14–0.81, log-rank test P=0.015). The implications of this work are substantial in counseling patients about their prognosis and in helping to assess responses to systemic therapies.

Login or register to post replies.

Hstevens0072's picture
Replies 3
Last reply 5/21/2013 - 7:46am
Replies by: Hstevens0072, Janner, kylez

....what is the status of the chat room? I've tried to get in a few times recently but just get a blank screen. I thought there was a temporary fix??

"The key is don't go to the funeral until the day of the funeral" ~ Valerie Harper

Login or register to post replies.

casagrayson's picture
Replies 3
Last reply 5/21/2013 - 5:23am
Replies by: aldakota22, POW, BrianP

I am rather new here, and don't know many people well.  I do, however, follow PeterO's blog @   Sadly, today's post shared news of Peter's passing early this morning.  



Saturday, May 18, 2013

The life that is truly life
We write with grateful but heavy hearts to share the news of Peter's passing this morning, May 18th, at 7:30 a.m. The loss we feel is profound, and yet we rejoice in faith that he is even now entering into the light of God's presence. He went in peace, surrounded by our prayers.
For those of you who are in the area and would like to come, a memorial service in honor of Peter's life will be held next Friday, May 24 at 2:30pm at Calvin Presbyterian Church in Corvallis. The reception following the service will be held at our home.
These past few weeks have been intense and sad, as we've cared for Peter in his steady decline. For those of you who are counting, Peter's death comes just a few days short of the 2-4 month prognosis his doctors gave us in March. If Peter were here to write this post, he'd certainly have plenty of conjectures about how and why his cancer went the way it did towards the end and what it all means medically. The truth is that we will never know - we simply rest in thanksgiving for Christ's presence with us, the Great Physician who knows the inner workings of our bodies and ordains the days of our life, and the moment of our death. Cancer did not have the final word in Peter's story. His journey has only begun now that he has passed into the "life that is truly life" (1 Tim. 6:19), where we trust he will live with God forever in his resurrected body.
We want to thank you all for your prayers, kind thoughts, phone calls, blog comments, messages, and words of encouragement during this time - our whole family has felt your care so deeply and truly sense our unity in Christ's love. We're especially thankful for the season of Pentecost that is now upon us, and trust that the Holy Spirit will come to our hearts to illuminate and console, as Jesus promised. We do not mourn as those who have no hope.

Strength and Courage,


Login or register to post replies.

The Melanoma Research Foundation continuously looks for innovative ways to raise awareness of melanoma and push for further research into new treatments.  One of the ways we do this is by speaking with media outlets on important topics related to melanoma education, research and advocacy. 

To help us spread these important messages, we are looking for volunteers willing to share their melanoma experiences with the media.  Depending on the opportunity, this may range from a personal story to a treatment plan.  If you are interested in helping the MRF raise melanoma awareness by speaking with the media about your personal experience, please take a few minutes to complete a short survey by visiting:

Thank you for your consideration.  The MRF will be in touch with you as media opportunities arise that match your experiences.  If you have any questions about this survey, please contact the MRF’s communications manager Lauren Smith at lsmith@melanoma.orgor 202-347-9675. 

With many thanks,

The MRF Team 

Login or register to post replies.

Erinmay22's picture
Replies 2
Last reply 5/20/2013 - 12:50pm
Replies by: Erinmay22, kylez
A few weeks ago I had an editor from Everyday Health ask if they could film me for a piece on Melanoma for awareness.  Here is what they put together. 
It's nice to hear more and more folks talking about it.  Although we always see discussions of it go up this time of the year!  
As as update on me - I had scans again this past week.  The lymph node they are watching continues to shrink.  The lung spot that showed up 4 weeks ago is gone.  There was a tiny spot on my L5 vertebrae but the doctor didn't seem concerned at all about that (but it's much easier for him not to worry...)  But still feeling pretty good!   And hopefully all heading in the right direction! 
Erin "people will forget what you said, people will forget what you did, but people will never forget how you made them feel' Maya Angelou

Login or register to post replies.

Melanoma Treatment Harnesses Immune System to Combat Cancer Cells


Published: May 15, 2013

Cancer researchers are growing increasingly enthusiastic about harnessing the body’s own immune system to fight tumors. And new research shows that two drugs that use this approach may be even better than one.

Researchers reported on Wednesday that a combination of two drugs from Bristol-Myers Squibb shrank tumors significantly in about 41 percent of patients with advanced melanoma in a small study. In few of the 52 patients in the study, tumors disappeared completely, at least as could be determined by imaging.

“I think it was really the rapidity and the magnitude of the responses that was impressive to us,” Dr. Jedd D. Wolchok of the Memorial Sloan-Kettering Cancer Center, said in a telephone news conference organized by the American Society of Clinical Oncology.

Dr. Wolchok’s study, and others on the immune system drugs, will be perhaps the most closely watched items at the society’s annual meeting, which begins on May 31 in Chicago.

The drugs are also generating huge interest on Wall Street, which projects billions of dollars in annual sales. While Bristol is generally considered to have a lead, Merck and Roche are not far behind with similar drugs.

Data released Wednesday from an early-stage study of Roche’s drug, which is known as MPDL3280A, showed significant tumor shrinkage in 21 percent of 140 patients who had a variety of cancers including lung, melanoma and kidney cancer.

The studies are small and they did not compare the drugs with a placebo or with another treatment, and it is unclear if they will lengthen lives. Moreover, it is unclear how long the effects will last, though there are signs that for many patients, it could be a year or more.

Cancer cells often successfully hide from the body’s immune system by preventing T-cells from attacking them. The new drugs basically work by disabling brakes on the immune system, allowing the T-cells to attack the tumors.

One of the drugs in Bristol-Myers’ combination is Yervoy, which was approved as a treatment for melanoma in 2011. Yervoy disables an immune system brake called CTLA-4. It shrinks tumors in only about 10 percent of patients, but the effects can last for a long time.

The other drug in its combination is nivolumab, which is not yet on the market. It disables a brake known as PD-1, which sits on the surface of T-cells. Tumors can produce a protein called PD-L1, which binds to PD-1 and makes the T-cells inactive.

Nivolumab, and the drug being developed by Merck, called MK-3475, are antibodies that bind to PD-1, while Roche’s drug binds to PD-L1. It is not clear yet which approach is better.

It may be possible to test tumors for the presence of PD-L1, and use the drugs mainly for those patients, where it is expected to work more effectively.

It is also not clear yet how many types of tumors the drugs will work for. All the companies are targeting melanoma, a deadly skin cancer, because there is evidence that it is sometimes controlled spontaneously by the immune system. The companies also have data for lung and kidney cancer. Roche’s study showed some effect in colorectal and head and neck cancer as well.

Bristol-Myers’s stock rose 5 percent on Wednesday, even though the results of the study were not released until 6 p.m., after the close of regular trading.

Mark Schoenebaum, the pharmaceutical analyst at ISI Group, said investors were hoping the combination of the two Bristol drugs would significantly shrink tumors in at least 50 percent of patients.

He said in a note on Wednesday that the overall shrinkage rate was perhaps a bit below expectations but added that for many patients, the shrinkage was more than 80 percent.

“The point is that the depth of those responses is pretty incredible,” he wrote.

Some experts say that tumor shrinkage, a measure that evaluates conventional chemotherapy drugs that poison cancer cells, may understate the effect of these new drugs.

“Sometimes it takes awhile for the immune system to be revved up,” said Dr. Gary Gilliland, who leads cancer drug development at Merck.

Login or register to post replies.

lrkg1234's picture
Replies 10
Last reply 5/19/2013 - 11:24am
Replies by: lrkg1234, kylez, aldakota22, Anonymous, MattF

We had a pretty crazy week at MD Anderson and not very good luck with our MRI, varying reports etc.  We still don't totally understand it and have had 3 opinions.  Please read below and let me know what you think. 

First doctor Patel calls us and says there are several areas on the brain that look like tumors, not sure how many, maybe some are scar tissue. She says that the radiologist says there was no contrast, but there clearly was and that she had other doctors agree that saw contrast.  She begins to tell us about possible SRS or Whole brain radiation.  I asked if she remembered that Scott has already had both SRS and Whole brain radiation.  She had not remembered that so things would obviously be different now.  She was not sure then if she could possibly be looking at scar tissue from the previous treatment.  NOT comforting, or cool waiting for several more days for an explanation.  The scan was done on Sunday and we didn't have an amended written report until yesterday, after we were back home in Indy.  


Here are the two reports, the preliminary and the amended. 


Technique, MRI of the brain without IV contrast-diffusion, axial T2 and axial flair were included. 

Findings:  There are areas of new T2 FLAIR hyperintensity in the left insula and bilateral left greater than the right anterior temporal lobes concerning for new foci of metastatic disease.  The previous enhancing lesions demonstrated are not well evaluated due to the noncontrast technique.  There is likely numerous enhancing lesions that have increased or that are new, however, cannot be evaluated due to noncontrast technique.  The orbital structures are unremarkable.  There There is no evidence for acute infarction.  The paranasal sinuses are clear.  There is mucosal thickening in the right mastoid air cells.  The left mastoid air cells are clear. 

Impression.  LIkely other foci of metastatic disease, however cannot be seen due to current technicque.  MRI with contrast is recommended. 


OK, then nothing else happens, no new MRI, just a change in report.  Here is the new ammended report. 


It appears that the patient had IV contrast, which was not pushed over to PACS and given that now these images have been pushed over, it is noted theat the patient is status post IV contrast.  Multiple enhancing lsions as dtailed below:  then goes on to list a total of 7 lesions.  Some of these are new when compared with the prior. 

So, my question is what is reality? 

We got the disc yesterday in the mail and gave it to the radiation oncologist office here.  He calls my husband last night and says that it might not be so bad as 7 tumors, it might just be 2 and then treatment would be possible.  He is home with a busted knee until for a week and a half and says that we can deal with it then, or see someone else.  He does not believe it will make a difference in Scott's treatment to wait a week or so. 

This is just craziness. I think they clearly screwed up the MRI at MD Anderson.  Bad news is hard enough to take, but it would be nice not to be told a few different things.  What does everyone think of these reports?  What does it exactly mean to "push" these images over? 

Thanks for the help.  Lisa

Login or register to post replies.

Gene_S's picture
Replies 1
Last reply 5/19/2013 - 1:57am
Replies by: Anonymous
Join Us!  The NaturalNews Healing Summit will be available
(online) at no cost - starting Mon. May. 20th - details below:

Live 4 today. Thank God for all he has done for us. Looking forward to enjoying tomorrow.

Login or register to post replies.


Strength and Courage,


Login or register to post replies.

SDJanku's picture
Replies 4
Last reply 5/18/2013 - 11:50pm
Replies by: Janner, malika, SDJanku

Our 3 year old boy, Gideon, had what we thought was a wart show up in November of last year, it was in the very center of his cheek. We thought it was a pimple, but it kept growing and was soon about 4 mm wide and tall and raised. We took him to the pediatrician, who tried to burn it off like a wart. Instead of turning black and falling off, it turned bright red, bled a lot and grew fast - it was 7 mm wide and 7 mm tall and 3mm above the skin when they sent us to the dermatologist. Derm did shave biopsy and those are the meausrements of what they removed three weeks ago. They sent it to pathology. It has grown to be the same size before shaving it in just three weeks and we see growth daily!

Pathology came back as unclear between atypical spitz nevi and malignant melanoma. I understand it is difficult to tell. They sent it back for further testing.

In the meantime, we were referred to an ENT to do a WLE (Wide Local Excision). We are being told the cut will be about three inches long (on his face) and will leave a good scar - it will go fairly deep too, since they predict that the mole goes deep.

The doctors we are seeing are not specialist with melanoma, and I understand juvenile melanoma is really rare. We live near Portland, OR and about three hours from Seattle, WA. We have family in Michigan and Minnesota and are willing to travel wherever to find the best treatment. Does anyone have any recommendations?

Also, what questions should I be asking the docs? Should they be doing a sentinal node biopsy? What else should I be asking?

There isn't much out there for kids - so any help is really appreciated!

Login or register to post replies.

Been a while since I posted. I do check on the board each day. Lynn finished the aberaxene wasnt much help. Talked about a clinical trial in Charlotte if brain was stable but the did a mri of brain. The 32 spots they treated are desd are dying only empty cavitys but of course there was 7 new ones and they offered gamma knife ahain they say it works so good for Lynn just dont know if hes up to the sixth one or not. They are talking about temador not to sure about that either. I dont think we have many options left. Lynn been really sick this week guess he picked up a virus at hospital Monday and on top of it the place they cut off on back got
infected. Its devasting the Drs havent give us much hope and Lynn wants to fight so bad

I have missed talking to my family on her and I have been wonder about gabsound.

Login or register to post replies.

TAC's picture
Replies 2
Last reply 5/18/2013 - 8:44pm
Replies by: kylez

Haven't been here in quite a while. Am Stage IIIb and have been for almost 12 years in spite of 6 recurrences..all surgically removed..all on the skin or just underneath. Have had 8 surgeries, 4 skin grafts, 2 sentinel node biopsies, chemo (interferon), radiation, a vaccine and then Leukine for 8 years. Fortunately none of the recurrences were in organs. I did have renal cell carcinoma (kidney removed) and in 2008 had adenocarcinoma (lung cancer and upper left lobe removed....I don't smoke). Been quite a journey in the cancer world but so far so good.

Chicken Soup for the Soul was soliciting stories for their Cancer Book. So I submitted a story called The Room of Hope, my story in the chemo room. It was included in the book. My view of the chemo room was and is that it is a place where Hope lives so I wrote it from that perspective. If you are interested in reading many good, hopeful and yes, sad stories, get the Chciken Soup for the Soul - The Cancer Book. My story is one of them.

Login or register to post replies.